NCT03400241View on ClinicalTrials.gov

Pharmacokinetic Study Comparing Tiotropium Easyhaler and Spiriva Handihaler

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

February 19, 2018

Primary Completion Date

April 18, 2018

Study Completion Date

April 18, 2018

Conditions
Healthy Subjects
Interventions
DRUG

Tiotropium Bromide Monohydrate

Tiotropium Easyhaler 10 mcg/dose Product A

DRUG

Tiotropium Bromide Monohydrate

Tiotropium Easyhaler 10 mcg/dose Product B

DRUG

Tiotropium Bromide Monohydrate

Tiotropium Easyhaler 10 mcg/dose Product C

DRUG

Tiotropium Bromide Monohydrate

Spiriva 18 Mcg/capsule inhaled via HandiHaler

Trial Locations (1)

Unknown

Clinical Pharmacology Unit, Espoo

All Listed Sponsors
lead

Orion Corporation, Orion Pharma

INDUSTRY

NCT03400241 - Pharmacokinetic Study Comparing Tiotropium Easyhaler and Spiriva Handihaler | Biotech Hunter | Biotech Hunter